NASDAQ: ORMP
Oramed Pharmaceuticals Inc Earnings Dates, Reports, Calls

Oramed Pharmaceuticals earnings were -$19.1M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest ORMP earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$10.2M, down 48.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ORMP reported annual earnings of -$19.1M, with -445% growth. The next ORMP earnings date is May 7, 2025.

ORMP earnings history

Current Revenue
$0.0
Current Earnings
-$19.1M
Current Profit Margin
0%

ORMP Return on Equity

Current Company
-11.8%
Current Industry
-2%
Current Market
34.1%
ORMP's Return on Equity (-11.8%)... subscribe to Premium to read more.
High Return on Equity Performance

ORMP undefined

Current Company
-10.8%
Current Industry
-0.4%
ORMP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ORMP announces earnings.

ORMP undefined

Current Company
-10.04%
Current Industry
5.9%
ORMP has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ORMP vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ORMP-$14.83M-$19.06MN/A-$0.48
COYA-$15.57M-$14.88MN/A-$0.98
ANIX-$12.45M-$12.48MN/A-$0.39
IMUX-$100.37M-$100.51MN/A-$1.00
GALT-$41.47M-$47.20MN/A-$0.76

ORMP earnings dates

Next earnings date
May 7, 2025

Oramed Pharmaceuticals Earnings Reports & History FAQ

What were Oramed Pharmaceuticals's earnings last quarter?

On ORMP's earnings call on Invalid Date, Oramed Pharmaceuticals (NASDAQ: ORMP) reported Q4 2024 earnings per share (EPS) of -$0.26, up 178.79% year over year. Total ORMP earnings for the quarter were -$10.19 million. In the same quarter last year, Oramed Pharmaceuticals's earnings per share (EPS) was $0.33.

If you're new to stock investing, here's how to buy Oramed Pharmaceuticals stock.

When does Oramed Pharmaceuticals report earnings?

The next ORMP earnings call is Invalid Date. Add ORMP to your watchlist to be reminded of Oramed Pharmaceuticals's next earnings date.

Is Oramed Pharmaceuticals profitable or losing money?

As of the last Oramed Pharmaceuticals earnings report, Oramed Pharmaceuticals is currently losing money. Oramed Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$19.06 million, a 444.98% decrease year over year.

What was ORMP's earnings growth in the past year?

As of Oramed Pharmaceuticals's earnings date in Invalid Date, Oramed Pharmaceuticals's earnings has grown year over year. ORMP earnings in the past year totalled -$19.06 million.

What are Oramed Pharmaceuticals's earnings expectations?

The current EPS estimate for Oramed Pharmaceuticals's earnings report in Invalid Date is -$0.05.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.